Successful use of activated recombinant factor VII to control bleeding abnormalities in a patient with a left ventricular assist device
- 1 February 2002
- journal article
- case report
- Published by Elsevier in The Journal of Thoracic and Cardiovascular Surgery
- Vol. 123 (2) , 384-385
- https://doi.org/10.1067/mtc.2002.119328
Abstract
No abstract availableThis publication has 3 references indexed in Scilit:
- Effect of the administration of recombinant activated factor VII (rFVIIa; NovoSeven®) in the management of severe uncontrolled bleeding in patients undergoing heart valve replacement surgeryBlood Coagulation & Fibrinolysis, 2000
- Preventing, minimizing, and managing postoperative bleedingThe Annals of Thoracic Surgery, 1999
- SUCCESSFUL USE OF RECOMBINANT FACTOR VIIa IN PATIENT WITH SEVERE HAEMOPHILIA A DURING SYNOVECTOMYThe Lancet, 1988